Exploiting cyanobacterial P450 pathways

Current Opinion in Microbiology

Volumn 13, Issue 3, 2010, Pages 301-306

  Robert, Faith O ^a   Pandhal, Jagroop ^a   Wright, Phillip C ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; ARTEMISININ; AVERMECTIN; BETA ELEMENE; CYTOCHROME P450; ERYTHROMYCIN; FUMITREMORGIN C; HECTOCHLORIN; MORPHINE; NATURAL PRODUCT; PACLITAXEL; UNCLASSIFIED DRUG; VINCRISTINE;

ANALGESIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; BACTERIAL GENE; BACTERIAL GENOME; BIOREMEDIATION; CYANOBACTERIUM; DRUG SYNTHESIS; ESCHERICHIA COLI; NONHUMAN; NOSTOC; NUCLEOTIDE SEQUENCE; OIL SPILL; REVIEW;

ALKANES; BACTERIAL PROTEINS; CYANOBACTERIA; CYTOCHROME P-450 ENZYME SYSTEM; ESCHERICHIA COLI; RECOMBINANT PROTEINS; SESQUITERPENES;

BACTERIA (MICROORGANISMS); CYANOBACTERIA; ESCHERICHIA COLI; EUKARYOTA; NOSTOC;

EID: 77952824272     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mib.2010.02.007     Document Type: Review

References (55)

1. Newman D.J., Cragg G.M., and Snader K.M. The influence of natural products upon drug discovery. Natural Product Reports 17 (2000) 215-234
2. Butler M.S. Natural products to drugs: natural product derived compounds in clinical trials. Natural Product Reports 22 (2005) 162-195
3. Wase N.V., and Wright P.C. Systems biology of cyanobacterial secondary metabolite production and its role in drug discovery. Expert Opinion on Drug Discovery 3 (2008) 903-929. This review highlights the importance of cyanobacterial secondary metabolite as drugs and drug leads, and the systems biology/synthetic biology paradigm for enhanced production.
4. Burja A.M., Banaigs B., Abou-Mansour E., Grant Burgess J., and Wright P.C. Marine cyanobacteria-a prolific source of natural products. Tetrahedron 57 (2001) 9347-9377
5. Schwarzer D., Finking R., and Marahiel M.A. Nonribosomal peptides: from genes to products. Natural Product Reports 20 (2003) 275-287
6. Newman D.J., and Cragg G.M. Natural products as sources of new drugs over the last 25 years. Journal of Natural Products 70 (2007) 461
7. Hanson J.R. Natural Products: the Secondary Metabolites (2003), Royal Society of Chemistry
8. Clardy J., and Walsh C. Lessons from natural molecules. Nature 432 (2004) 829-837
9. Edwards P.A., and Ericsson J. Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway. Annual Review of Biochemistry 68 (1999) 157-185
10. Harvey A.L. Natural products in drug discovery. Drug Discovery Today 13 October (2008) 894-901. This paper reviews the sources and diversity of natural products used as drugs and drug leads while emphasising modern and cost effective methods of natural product utilisation.
11. Harel Y., Ohad I., and Kaplan A. Activation of photosynthesis and resistance to photoinhibition in cyanobacteria within biological desert crust. Plant Physiology 136 (2004) 3070
12. Herrero A., and Flores E. The Cyanobacteria (2008), Horizon Scientific Press
13. Smee D.F., Bailey K.W., Wong M.H., O'Keefe B.R., Gustafson K.R., Mishin V.P., and Gubareva L.V. Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N. Antiviral Research 80 (2008) 266-271
14. Hoffmann D., Hevel J.M., Moore R.E., and Moore B.S. Sequence analysis and biochemical characterization of the nostopeptolide A biosynthetic gene cluster from Nostoc sp. GSV224. Gene 311 June (2003) 171-180
15. Trimurtulu G., Ohtani I., Patterson G.M., Moore R.E., Corbett T.H., Valeriote F.A., and Demchik L. Total structures of cryptophycins, potent antitumor depsipeptides from the blue-green alga Nostoc sp. strain GSV 224. Journal of the American Chemical Society 116 (1994) 4729-4737
16. Ikawa M., Sasner J.J., and Haney J.F. Activity of cyanobacterial and algal odor compounds found in lake waters on green alga Chlorella pyrenoidosa growth. Hydrobiologia 443 (2001) 19-22
17. Agger S.A., Lopez-Gallego F., Hoye T.R., and Schmidt-Dannert C. Identification of sesquiterpene synthases from Nostoc punctiforme PCC 73102 and Nostoc sp. strain PCC 7120. Journal of Bacteriology 190 (2008) 6084. This paper is the first report of functional heterologous co-expression of a sesquiterpene synthase and a cytochrome P450 in a cyanobacterial species. It shows in vivo evidence of the tailoring activity of cytochrome P450 on the sesquiterpene olefin from the sesquiterpene pathway.
18. Nebert D.W., Nelson D.R., and Feyereisen R. Evolution of the cytochrome P450 genes. Xenobiotica 19 (1989) 1149-1160
19. Bernhardt R. Cytochromes P450 as versatile biocatalysts. Journal of Biotechnology 124 June (2006) 128-145
20. Nelson D.R., Koymans L., Kamataki T., Stegeman J.J., Feyereisen R., Waxman D.J., Waterman M.R., Gotoh O., Coon M.J., Estabrook R.W., et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6 February (1996) 1-42
21. Hannemann F., Bichet A., Ewen K.M., and Bernhardt R. Cytochrome P450 systems-biological variations of electron transport chains. Biochimica et Biophysica Acta (BBA) - General Subjects 1770 March (2007) 330-344
22. Montellano P.R.O.D. Cytochrome P450 (2005), Springer
23. Degtyarenko K.N., and Archakov A.I. Molecular evolution of P450 superfamily and P450-containing monooxygenase systems. FEBS Letters 332 (1993) 1-8
24. Ioannides C. Cytochromes P450 (1996), CRC Press
25. Spatzenegger M., and Jaeger W. Clinical importance of hepatic cytochrome P450 in drug metabolism. Drug Metabolism Reviews 27 (1995) 397-417
26. Lamb D.C., Waterman M.R., Kelly S.L., and Guengerich F.P. Cytochromes P450 and drug discovery. Current Opinion in Biotechnology 18 (2007) 504-512. This paper reviews the importance of cytochrome P450 in drug discovery, the potential for CYP engineering to produce novel compounds and exploiting CYPs as drug targets in pathogenic microbes.
27. Lewis D.F.V. Guide to Cytochromes P450 (2001), CRC Press
28. Edwards D.J., Marquez B.L., Nogle L.M., McPhail K., Goeger D.E., Roberts M.A., and Gerwick W.H. Structure and biosynthesis of the jamaicamides, new mixed polyketide-peptide neurotoxins from the marine cyanobacterium Lyngbya majuscula. Chemistry & Biology 11 June (2004) 817-833
29. Cupp-Vickery J.R., and Poulos T.L. Structure of cytochrome P450eryF involved in erythromycin biosynthesis. Nature Structural & Molecular Biology 2 (1995) 144-153
30. Unterlinner B., Lenz R., and Kutchan T.M. Molecular cloning and functional expression of codeinone reductase: the penultimate enzyme in morphine biosynthesis in the opium poppy Papaver somniferum. The Plant Journal 18 (1999) 465-475
31. Schwab W. Metabolome diversity: too few genes, too many metabolites?. Phytochemistry 62 March (2003) 837-849
32. Estabrook R.W. A Passion for P450s (remembrance of the early history of research on cytochrome P450). Drug Metabolism and Disposition 31 December (2003) 1461-1473
33. Ke N., Baudry J., Makris T.M., Schuler M.A., and Sligar S.G. A retinoic acid binding cytochrome P450: CYP120A1 from Synechocystis sp. PCC 6803. Archives of Biochemistry and Biophysics 436 April (2005) 110-120. This paper describes the first cloning, heterologous expression and functional characterisation of a cytochrome P450 protein from a cyanobacterial species and application of binding assays and homology modelling to show binding of retinoic acid by CYP120A1.
34. Kühnel K., Ke N., Cryle M.J., Sligar S.G., Schuler M.A., and Schlichting I. Crystal structures of substrate-free and retinoic acid-bound cyanobacterial cytochrome P450 CYP120A1. Biochemistry 47 (2008) 6552-6559. This paper describes the first reported structural characterisation of a cyanobacterial P450 protein. The elucidation of the crystal structures of substrate-free and all-trans retinoic acid bound CYP120A1 from Synechocystis sp. PCC 6803 gave an indication that it is involved in retinoic acid metabolism.
35. Alder A., Bigler P., Werck-Reichhart D., and Al-Babili S. In vitro characterization of Synechocystis CYP120A1 revealed the first nonanimal retinoic acid hydroxylase. The FEBS Journal 276 October (2009) 5416-5431. In this paper, direct evidence of retinoic acid metabolism by CYP120A1 from Synechocystis sp. 6803 by in vitro assay was demonstrated, which is the first reported in vitro characterisation of a cyanobacterial P450 protein.
36. Simmons T.L., Andrianasolo E., McPhail K., Flatt P., and Gerwick W.H. Marine natural products as anticancer drugs. Molecular Cancer Therapeutics 4 (2005) 333
37. Faulkner D.J. Marine natural products. Natural Product Reports 15 (1998) 113-158
38. Jones A.C., Gu L., Sorrels C.M., Sherman D.H., and Gerwick W.H. New tricks from ancient algae: natural products biosynthesis in marine cyanobacteria. Current Opinion in Chemical Biology 13 (2009) 216-223
39. Torres S., Fjetland C.R., and Lammers P.J. Alkane-induced expression, substrate binding profile, and immunolocalization of a cytochrome P450 encoded on the nifD excision element of Anabaena 7120. BMC Microbiology 5 (2005) 1-12
40. Keasling J.D. Microbial production of isoprenoids. Handbook of Hydrocarbon and Lipid Microbiology (2010) 2951-2966
41. Kirby J., and Keasling J.D. Biosynthesis of plant isoprenoids: perspectives for microbial engineering. Annual Review of Plant Biology 60 (2009) 335-355. This paper reviews efforts aimed at total microbial biosynthesis of many important plant based isoprenoid compounds such as artemisinin and taxol in order to meet global demands and at affordable prices.
42. Hasan R.H., Sorkhoh N.A., Bader D., and Radwan S.S. Utilization of hydrocarbons by cyanobacteria from microbial mats on oily coasts of the Gulf. Applied Microbiology and Biotechnology 41 (1994) 615-619
43. Cardini G., and Jurtshuk P. Cytochrome P-450 involvement in the oxidation of n-octane by cell-free extracts of Corynebacterium sp. strain 7E1C. Journal of Biological Chemistry 243 (1968) 6070
44. Ashby M.K., and Houmard J. Cyanobacterial two-component proteins: structure, diversity, distribution, and evolution. Microbiology and molecular biology reviews 70 June (2006) 472-509
45. Pietra F. A Secret World (1990), Birkhäuser Verlag
46. Otey C.R., Silberg J.J., Voigt C.A., Endelman J.B., Bandara G., and Arnold F.H. Functional evolution and structural conservation in chimeric cytochromes P450 calibrating a structure-guided approach. Chemistry & Biology 11 (2004) 309-318
47. Ramaswamy A.V., Sorrels C.M., and Gerwick W.H. Cloning and biochemical characterization of the hectochlorin biosynthetic gene cluster from the marine cyanobacterium Lyngbya majuscula. Journal of Natural Products 70 (2007) 1977-1986
48. Lamb D.C., Guengerich F.P., Kelly S.L., and Waterman M.R. Exploiting Streptomyces coelicolor A3(2) P450s as a model for application in drug discovery. Expert Opinion on Drug Metabolism & Toxicology 2 (2006) 27-40
49. Lamb D.C., Ikeda H., Nelson D.R., Ishikawa J., Skaug T., Jackson C., Omura S., Waterman M.R., and Kelly S.L. Cytochrome P450 complement (CYPome) of the avermectin-producer Streptomyces avermitilis and comparison to that of Streptomyces coelicolor A3 (2). Biochemical and Biophysical Research Communications 307 (2003) 610-619
50. Walker K., and Croteau R. Taxol biosynthetic genes. Phytochemistry 58 (2001) 1-7
51. Bertea C.M., Freije J.R., Van der Woude H., Verstappen F.W., Perk L., Marquez V., De Kraker J.W., Posthumus M.A., Jansen B.J., De Groot A.E., et al. Identification of intermediates and enzymes involved in the early steps of artemisinin biosynthesis in Artemisia annua. Planta Medica 71 (2005) 40-47
52. Pauli H.H., and Kutchan T.M. Molecular cloning and functional heterologous expression of two alleles encoding methylcoclaurine 3′hydroxylase (CYP80B1), a new methyl jasmonate inducible cytochrome P450 dependent monooxygenase of benzylisoquinoline alkaloid biosynthesis. The Plant Journal 13 (1998) 793-801
53. Schröder G., Unterbusch E., Kaltenbach M., Schmidt J., Strack D., De Luca V., and Schröder J. Light-induced cytochrome P450-dependent enzyme in indole alkaloid biosynthesis: tabersonine 16-hydroxylase. FEBS Letters 458 (1999) 97-102
54. Grundmann A., Kuznetsova T., Afiyatullov S.S., and Li S.M. FtmPT2, an N-prenyltransferase from Aspergillus fumigatus, catalyses the last step in the biosynthesis of fumitremorgin B. Chembiochem 9 (2008) 2059-2063
55. Nelson D.R., Kamataki T., Waxman D.J., Guengerich F.P., Estabrook R.W., Feyereisen R., Gonzalez F.J., Coon M.J., Gunsalus I.C., Gotoh O., et al. The P450 Superfamily: Update on New Sequences, Gene Mapping, Accession Numbers, Early Trivial Names of Enzymes, and Nomenclature. DNA and Cell Biology 12 (1993) 1-51